Michiko Nagamine

7PUBLICATIONS
62CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AllergyPredictive and prognostic markersVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 28, 2026
Correction: Congophilic fibrillary glomerulonephritis recurrence post-renal transplant: diagnostic challenges and proteomic insights.

|May 29, 2026
Feasibility study of photoimmunotherapy combination with ASP-1929 for vulvar, vaginal, and cervical cancer.

|May 22, 2026
Hokkaido phase II study of photo-immunotherapy combination with ASP-1929 for recurrent or persistent EGFR-positive vulvar, vaginal, and cervical cancers not amenable to further radiotherapy (HICARi study).

|Jan 22, 2026
Congophilic fibrillary glomerulonephritis recurrence post-renal transplant: diagnostic challenges and proteomic insights.

Hiroshi Watanabe, Michiko Nagamine, Yukako Shintani-Domoto

|Jan 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto

|Jul 18, 2024
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine.

Tadayoshi Hashimoto, Yoshiaki Nakamura, Takao Fujisawa

Pageof 2

Frequent Collaborators

3 joint publications

Kanako C Hatanaka

3 joint publications

Yutaka Hatanaka

2 joint publications

Eiji Oki

2 joint publications

Yoshiaki Nakamura